GGrantIndex
Sort

23,748 grants matching melanoma

Involving older adults in decision making for skin cancer

$214,702
Eleni Linos · University Of California, San Francisco · K76 · FY2017 · AG

Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents

$214,681
Donald D Muccio · University Of Alabama At Birmingham · P01 · FY2017 · CA

Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents

$214,681
Matthew B Renfrow · University Of Alabama At Birmingham · P01 · FY2018 · CA

Pilot Investigation of Behavioral Alternatives to Indoor Tanning

$214,673
Sherry L Pagoto · Univ Of Massachusetts Med Sch Worcester · R21 · FY2012 · CA

Striatal Dopamine Release in Response to Ultraviolet Light in Compulsive Tanners

$214,594
Bryon H Adinoff · Ut Southwestern Medical Center · R21 · FY2012 · AR

Mechanisms of Th17-DC immunotherapy for ovarian cancer

$214,583
Martin J Cannon · Univ Of Arkansas For Med Scis · R21 · FY2024 · CA

Uncovering the role of m6A in the melanocyte response to ultraviolet light

$214,562
Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · R21 · FY2019 · CA

A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer

$214,552
Adam B Glick · Pennsylvania State University, The · R01 · FY2007 · CA

Role of RGS proteins in Ras- and B-Raf--mediated transformation

$214,543
Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA

A Mouse Model of TGFB1 and Tumor Immunosurveillance in Squamous Cell Cancer

$214,522
Adam B Glick · Pennsylvania State University, The · R01 · FY2009 · CA

ANTI-NEOPLASTIC EFFECTS OF GAMMA-SECRETASE INHIBITORS

$214,516
Lucio Miele · University Of Massachusetts Amherst · P01 · FY2010 · AG

Palmitoylation of Hedgehog Proteins

$214,512
Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM

Overcoming therapy resistance in melanoma

$214,505
Zhi Sheng · Virginia Polytechnic Inst And St Univ · R21 · FY2024 · CA

Inducing Chromosomal Damage Responses in Pancreatic Cancer

$214,500
Douglas V Faller · Boston University Medical Campus · R21 · FY2010 · CA

EB1 protein: regulator of actin protrusion and cell motility

$214,500
Joseph Martin Schober · Southern Illinois Univ At Edwardsville · R15 · FY2011 · GM

Chemoattractant-based immunotherapeutics to modulate immune and cancer cells

$214,480
Arya Biragyn · National Institute On Aging · Z01 · FY2008 · AG

Understanding PD-L1/L2 protein regulation, detection and signaling to predict melanoma therapeutic sensitivity

$214,414
Roger S Lo · University Of California Los Angeles · R21 · FY2022 · CA

ROLE OF EWS ATF1 IN NEOPLASIA

$214,404
Mcp Hahnemann University · R01 · FY2000 · CA

Tissue-Based Cytokine Immunotherapy for Skin Cancer

$214,392
Mary A. Lokuta · Stratatech Corporation · R44 · FY2011 · CA

Functions of the DNA/RNA motor protein AQR in R-loop resolution

$214,350
Xiaoyu Xue · Texas State University · R21 · FY2019 · ES

MATCHMAKERS: SOLVING TCR RECOGNITION AND DESIGN VIA INTEGRATED HIGH-THROUGHPUT SCREENING, STRUCTURAL, FUNCTIONAL, AND COMPUTATIONAL APPROACHES

$214,343
Kenan Christopher Garcia · Stanford University · OT2 · FY2024 · CA

Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure

$214,340
Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2023 · CA

Core A - Administrative

$214,336
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA

DEVELOPMENTAL BASES FOR PIGMENT CELL VARIATION IN DANIO

$214,286
University Of Texas Austin · R01 · FY2001 · GM

Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome

$214,268
Jason Keith Sicklick · University Of California, San Diego · R21 · FY2017 · CA